Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review

Table 1 Noninvasive prognostic tests for primary sclerosing cholangitis

Serum markers	Models	Elastography	Imaging
Alkaline phosphatase; Total bilirubin; Enhanced liver fibrosis score	Mayo Risk Score; UK-PSC score; Amsterdam-Oxford Model; PREsTo score	Vibration controlled transient elastography; Magnetic resonance elastography	Magnetic resonance imaging-Anali score

PSC: Primary sclerosing cholangitis; PREsTo: Primary sclerosing risk estimate tool.

Table 2 Variables in noninvasive prognostic models for primary sclerosing cholangitis

	MRS	AOM	PREsTo	UK-PSCST	UK-PSCLT
Age	√	√
PSC subtype		√			√
Albumin	√	√	√	√
ALP		√	√		√
AST	√		√
Hemoglobin			√	√
Platelets		√	√	√	√
Sodium			√
Total bilirubin	√	√	√	√	√
Variceal bleed	√				√

AOM: Amsterdam-Oxford Model; ALP: Alkaline phosphatase; AST: Aspartate transaminase; MRS: Mayo Risk Score; PSC: Primary sclerosing cholangitis; PREsTo: Primary sclerosing risk estimate tool.